Professor of Medicine, Johns Hopkins University School of Medicine; Director, Hospitalist Program, The Johns Hopkins Hospital
Internal Medicine
Dr. Daniel J. Brotman, MD
|
|
Give Review
Daniel Brotman works in the field of Internal Medicine. He graduated from University of Virginia School of Medicine. Daniel Brotman is a published doctor as well. He has 93 publications published. The latest was: Suppression of melatonin secretion in some blind patients by exposure to bright light. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Association between days to complete inpatient discharge summaries with all-payer hospital readmissions in Maryland.
- The authors reply "Changes in patient satisfaction related to hospital renovation: The experience with a new clinical building".
- Changes in patient satisfaction related to hospital renovation: Experience with a new clinical building.
- Characteristics of primary care providers who adopted the hospitalist model from 2001 to 2009.
- Use of provider-level dashboards and pay-for-performance in venous thromboembolism prophylaxis.
- Patients' understanding of their hospitalizations and association with satisfaction.
- Decision support tool use in colorectal surgery: what is the role?
- Association of impaired functional status at hospital discharge and subsequent rehospitalization.
- Identifying potential predictors of a safe attending physician workload: A survey of hospitalists.
- The Effectiveness of Prophylactic Inferior Vena Cava Filters in Trauma Patients: A Systematic Review and Meta-analysis.
- A systematic review of venous thromboembolism prophylaxis strategies in patients with renal insufficiency, obesity, or on antiplatelet agents.
- Pharmacologic and Mechanical Strategies for Preventing Venous Thromboembolism After Bariatric Surgery: A Systematic Review and Meta-analysis.
- Impact of providing fee data on laboratory test ordering: a controlled clinical trial.
- Association of self-reported hospital discharge handoffs with 30-day readmissions.
- Provider cost transparency alone has no impact on inpatient imaging utilization.
- Insurance status, not race, is associated with mortality after an acute cardiovascular event in Maryland.
- Hospital care and medical utilization after discharge.
- Hospitalists, PCPs, specialists, and non-physicians: Too many cooks in the kitchen?
- Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
- Heart rate variability predicts ESRD and CKD-related hospitalization.
- Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A.
- Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.
- Impact of a restrictive antimicrobial policy on the process and timing of antimicrobial administration.
- Perioperative anticoagulant management.
- Retrievable vena cava filters: a clinical review.
- Usefulness of cystatin C and prognosis following admission for acute heart failure.
- Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
- Outcomes of genetic testing in adults with a history of venous thromboembolism.
- Paging Goldilocks: how much glycemic control is just right?
- Prevention of venous thromboembolism after surgery.
- Perioperative statins: more than lipid-lowering?
- Racial differences in diurnal blood pressure and heart rate patterns: results from the Dietary Approaches to Stop Hypertension (DASH) trial.
- Length of stay and mortality in pulmonary embolism: high time for evidence-based discharge criteria.
- Prevention of venous thromboembolism in the cancer surgery patient.
- Prevention of venous thromboembolism in the orthopedic surgery patient.
- Prevention of venous thromboembolism in the hospitalized medical patient.
- Outcomes of patients with stable heart failure undergoing elective noncardiac surgery.
- Impaired diurnal blood pressure variation and all-cause mortality.
- Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study.
- Missing the forest for the trees.
- Beyond cardiovascular risk: the impact of obesity on cancer death.
- When can patients with acute deep vein thrombosis be allowed to get up and walk?
- Computed tomography for pulmonary embolism.
- Mediators of the association between mortality risk and socioeconomic status.
- Clinical problem-solving. Ring around the diagnosis.
- Association of impaired diurnal blood pressure variation with a subsequent decline in glomerular filtration rate.
- Presentation of diagnostic test accuracy.
- Prevention of venous thromboembolism in the geriatric patient.
- Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers.
- Hospital-acquired gastrointestinal bleeding outside the critical care unit: risk factors, role of acid suppression, and endoscopy findings.
- Relation of brachial artery reactivity to nitroglycerin and heart rate recovery following exercise in healthy male volunteers.
- "Regression" of adiposity with more sleep.
- Effects of short-term glucocorticoids on cardiovascular biomarkers.
- Duration of anesthesia and venous thromboembolism after hip and knee arthroplasty.
- Current and emerging options in the management of venous thromboembolism.
- In search of fewer independent risk factors.
- Relation of diurnal blood pressure variation and triglyceride-to-high-density lipoprotein cholesterol ratio in patients without diabetes mellitus.
- Low-molecular-weight heparin or stockings for preventing coach class thrombosis?
- Why not test for hypercoagulability in patients with idiopathic venous thromboembolism?
- Acute splenic sequestration crisis resembling sepsis in an adult with hemoglobin SC disease.
- Virchow's triad revisited.
- Identifying patients at risk of recurrent venous thromboembolism.
- Postmenopausal hormones and glycemic effects.
- Should patients on warfarin for 3 months for idiopathic proximal deep venous thrombosis receive bridging therapy precolonoscopy (with expected biopsy)?
- When patients on warfarin need surgery.
- Rational use of D-dimer measurement to exclude acute venous thromboembolic disease.
- The JNC 7 hypertension guidelines.
- Can glucocorticoid homeostasis explain the antiatherogenic effect of peripheral adiposity?
- Does glucocorticoid dysregulation contribute to the link between cigarette smoking and insulin resistance?
- Acetaminophen and hypertension: a causal association or pain mediated?
- Limitations of D-dimer testing in unselected inpatients with suspected venous thromboembolism.
- Narrow-complex tachycardia in an elderly patient with presyncope.
- Spinal metastasis as the initial manifestation of a nonsecretory glucagonoma.
- Increase in nocturnal blood pressure and progression to microalbuminuria in diabetes.
- The metabolic syndrome: a tug-of-war with no winner.
- 'Coach class thrombosis': is the risk real? What do we tell our patients?
- Effects of counterregulatory hormones in a high-glycemic index diet.
- The cardiovascular toll of stress.
- Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment.
- Warfarin prophylaxis and venous thromboembolism in the first 5 days following hip and knee arthroplasty.
- Acute ophthalmoplegia.
- Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
- The metabolic syndrome as a vicious cycle: does obesity beget obesity?
- Photic resetting of the human circadian pacemaker in the absence of conscious vision.
- Suppression of melatonin secretion in some blind patients by exposure to bright light.
- Syphilis and orthostatic shaking limbs.
- Primary angiitis of the central nervous system and Alzheimer''s disease: clinically and pathologically evident in a single patient.
- Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.
- Observational versus randomised trial evidence.
- Infallibility of a normal platelet count/spleen diameter ratio in ruling out oesophageal varices?
- Does altered glucocorticoid homeostasis increase cardiovascular risk?
- Avatar-based interactive ileostomy education in hospitalized patients.
Schools
University of Virginia Main Campus
Johns Hopkins Hospital
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Johns Hopkins University -
University of Virginia School of Medicine
Hospital
-
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1285691451 | |
| NPPES Provider LastName | BROTMAN | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 59.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1285691451 |
| Last Name Of The Provider | BROTMAN |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Rachel M. Kruzan, MD |
|
|
Dr. Yuenting D. Kwong, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jessica V. Lumsden, DO |
|
|
Dr. Paul T. Barbera Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary J. Noronha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dhaval Desai, MD |
|
|
Dr. Philip F. Panzarella, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathon M. Thorp, MD |
|
|
Ronnie J. Morris |